Article Details

Swedish rare disease drugmaker Sobi to go private in $8B takeover by Advent, GIC | FiercePharma

Retrieved on: 2021-09-02 15:20:46

Tags for this article:

Click the tags to see associated articles and topics

Swedish rare disease drugmaker Sobi to go private in $8B takeover by Advent, GIC | FiercePharma. View article details on hiswai:

Excerpt

After AstraZeneca's $39 billion acquisition of Alexion, another rare disease drugmaker has become the target of a takeover. Thursday, Swedish biotech Sobi said ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up